(Date:11/9/2009)... LAS VEGAS, Nov. 9 CBS Vision, the...gency OMD, an Omnicom Media Group company, today a...w OMD,s clients access to the CBS Television City ... Las Vegas. ,, The new venture, which marries ...nty,s leading agencies, will be called Communicati...
(Date:11/9/2009)..., N.Y. Oncologists have had their hands tied beca...ions that disable a protein called p53. As a criti...cancer-fighting operations within cells. When cell...not be treated. , These tumors might be tough, ...rom Cold Spring Harbor Laboratory (CSHL). The chin...
(Date:11/9/2009)...f butterfly wings has inspired a 3.2m, three-year ...on in the fields of security, energy and the envir... technology company QinetiQ have just signed a col...sed on groundbreaking physical sciences research. ...s from the University of Exeter and QinetiQ will w...
Breaking Biology News(10 mins):CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2Finances Trigger American Reluctance to Spend More on Healthier Foods 49018 1Finances Trigger American Reluctance to Spend More on Healthier Foods 49018 2Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 1Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 2Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 3AirClic Mobile Business Solutions Clic for Bio Reference Laboratories Inc 49012 1AirClic Mobile Business Solutions Clic for Bio Reference Laboratories Inc 49012 2(Date:11/6/2009)... Helix BioPharma Corp. (T...ed that John Docherty, president and chief operati... 6th annual Investor Summit on November 10, 2009 a...Mr. Docherty will provide an overview of the Compa...and Topical Interferon Alpha-2b. The slide show p...
(Date:11/6/2009)...ember 6 EUCODIS Bioscience, a comp...rketing enzymes for the,chemical industry announce...ent with Bio Sidus, the leading biopharmaceutical ... gives EUCODIS Bioscience exclusive access - for t...roprietary collection of,psychrophilic bacteria st...
(Date:11/6/2009)...ov. 6 Calbiotech, Inc. announced t...ovative Research (SBIR) Phase I contract by the U....er terms of the agreement, Calbiotech will develop...s of Dengue virus. ,, Dengue virus is a mosq...t to military forces deployed to tropical areas of...
(Date:11/6/2009)... Intarcia Therapeutics, Inc. delive...® continuous delivery of exenatide) program f...nnual Diabetes Technology Meeting in San Francisco.../prnh/20050301/SFTU126LOGO ) ,, Continuous Su...rs Plasma Glucose, HbA1c and Reduces Weight in a 2...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5....S. Patent and Trade Office issued U.S. Patent No....lymerase and Uses Thereof to the Wisconsin Alumni...y of the University of Wisconsin-Madison. ConjuGo...lectual property invented by its co-founder Richar...research group, which included ConjuGon scientist ...
...le System was chosen by Popular Science magazine ..., ,To be among the 100 selected by Popular Science...chnology must represent a significant step forward...ble System features In-Cell Charge Control (I-C3)t... the battery, instead of the charger. This breakt...
...built the supply chain industries first fully func...adio frequency identification (RFID) laboratory d...vironment. The RFID Lab is enabling RedPrairie cus...t and readability as they prepare for RFID complia...scenarios, the RFID Lab is helping companies deter...
Other Biology Technology:RedPrairie Builds RFID Lab - Enables Real-World Testing 2Bovine IgG2 ELISA Kit from Bethyl Laboratories
Dog IgE ELISA Kit from Bethyl Laboratories
PCP ELISA Kit, Single from Bio-Quant Inc.
...Protocol Development ,Antibody Titer and Optimal C...or Human Cells and Tissues ,Double Antibody Labeli...phatase, Immunogold, and Fluorescent detection ,Li...Localization in Transgenic Animals ,Hundreds of Sp...
Biology Products: